XB-IMG-175399
Xenbase Image ID: 175399
|
Supplemental Figure 5: Knockdown of pTEFb components CDK9a or CyclinT1 does not affect expression of neural markers.
All embryos were injected in one cell of a two cell stage embryo with either a control morpholino CoMo, 100ng CDK9b morpholino or 60ng CyclinT1 morpholino. 300pg of Lac-Z cRNA was co-injected with morpholinos and β-gal activity was detected using a red gal stain to monitor lineage tracing. in situ hybridisation was then carried out on these embryos for neural markers. Como injected Hbox6 n=29, Engrailed n=31, Krox20 n=31, Otx2 n=29, Ncam n=26, N-tubulin n=32. Cdk9a mo injected Hbox6 n=20, Engrailed n=30, Krox20 n=31, Otx2 n=25, Ncam n=26, N-tubulin n=35. CyclinT1 mo injected Hbox6 n=27, Engrailed n=21, Krox20 n=33, Otx2 n=28, Ncam n=26, N-tubulin n=27. DMSO treated Hbox6 n=18, Engrailed n=22, Krox20 n=34, Otx2 n=31, Ncam n=19, N-tubulin n=20. Leflunomide treated Hbox6 n=30, Engrailed n=28, Krox20 n=34, Otx2 n=31, Ncam n=31, N-tubulin n=32. Image published in: Hatch VL et al. (2016) Copyright © 2016. Image reproduced with permission of the Publisher, Elsevier B. V.
Image source: Published Larger Image Printer Friendly View |